Common osteoporosis drug may reduce risk of type 2 diabetes
New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, suggests that the widely used osteoporosis drug alendronate reduces the risk of type 2 diabetes.
source https://medicalxpress.com/news/2021-09-common-osteoporosis-drug-diabetes.html
source https://medicalxpress.com/news/2021-09-common-osteoporosis-drug-diabetes.html
Comments
Post a Comment